OTC · Financial Statements
Paradigm Biopharmaceuticals Limited (PBIGF) Financial Statements
$0.12
OTC: PBIGF
Market Cap $52.01M
Overview Financials Dividend Paradigm Biopharmaceuticals Limited most recently reported annual revenue of $0, net profit of $-19.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-43.0M $-48.0M $-60.0M $-65.0M $-23.0M Net Profit $-34.0M $-39.0M $-52.0M $-59.0M $-19.0M EPS $-0.16 $-0.16 $-0.18 $-0.20 $-0.06 Op Margin -210124.4% -60498.8% -128497.1% -99077.5% -43910.6%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $85.0M $51.0M $67.0M $27.0M $25.0M Total Liabilities $7.0M $8.0M $13.0M $4.0M $3.0M Cash $71.0M $40.0M $56.0M $18.0M $17.0M Borrowings $1.0M $1.0M $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-35.0M $-32.0M $-45.0M $-66.0M $-16.0M Investing Cash Flow $1.0M $0 $0 $66.0M $0 Financing Cash Flow $0 $0 $-4.0M $0 $0 Net Cash Flow $-33.0M $-31.0M $17.0M $-39.0M $-1.0M Free Cash Flow $-35.0M $-32.0M $-45.0M $-66.0M $-16.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.02 EV / EBITDA -1.47 FCF Yield -10.55% Quick Ratio 1.31 Interest Coverage -29.37 Return 1Y -47.51% Return 3Y -80.57% Return 5Y —
Screens featuring this stock